Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine, cocaine ...

When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic. “I do ...

(res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ ...

The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine ...

While inducing GLP-1, the drug also reduces GIP activity ... CB1 plays an important role in appetite regulation and cardiometabolic pathways,” explains the Novo Nordisk spokesperson. A previous drug ...

One of the primary benefits of Health Journey GLP-1 Booster is its ability to support normal metabolic function. The supplement’s unique blend of probiotics and prebiotics works synergistically to ...